TUXYN 10 MG/ML SOL DIL INFUS CT 2 FR VD TRANS X 10 ML
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1453100050011 -
GGREM
556926020000607 -
Barcode
7898976181020
What the source publishes
- Holder
- BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA
- Active ingredients
- RITUXIMABE
- Package
- 10 MG/ML SOL DIL INFUS CT 2 FR VD TRANS X 10 ML
- Supply regime
- Tarja Vermelha
- Product type
- Biológico
- Therapeutic class
- L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TUXYN 10 MG/ML SOL DIL INFUS CT 2 FR VD TRANS X 10 ML",
"holder": "BIONOVIS S.A. - COMPANHIA BRASILEIRA DE BIOTECNOLOGIA FARMACEUTICA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898976181020"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "556926020000607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": true,
"holderTaxId": "12.320.079/0001-17",
"priceRegime": "Regulado",
"productName": "TUXYN",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "10 MG/ML SOL DIL INFUS CT 2 FR VD TRANS X 10 ML",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "3623.52",
"icms-12": "4117.64",
"icms-17": "4365.69",
"icms-18": "4418.93",
"icms-19": "4473.48",
"icms-20": "4529.40",
"icms-21": "4586.73",
"icms-22": "4645.54",
"icms-23": "4705.87",
"icms-17.5": "4392.14",
"icms-19.5": "4501.27",
"icms-20.5": "4557.89",
"icms-22.5": "4675.51",
"icms-12-alc": "4068.22",
"icms-17-alc": "4313.30",
"icms-18-alc": "4365.90",
"icms-19-alc": "4419.80",
"icms-20-alc": "4475.04",
"icms-21-alc": "4531.69",
"icms-22-alc": "4589.79",
"icms-23-alc": "4649.40",
"withoutTaxes": "3580.04",
"icms-17.5-alc": "4339.44",
"icms-19.5-alc": "4447.25",
"icms-20.5-alc": "4503.19",
"icms-22.5-alc": "4619.40"
},
"pisCofinsList": "Positiva",
"substanceText": "RITUXIMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "4994.64",
"icms-12": "5675.74",
"icms-17": "6017.65",
"icms-18": "6091.03",
"icms-19": "6166.23",
"icms-20": "6243.31",
"icms-21": "6322.33",
"icms-22": "6403.39",
"icms-23": "6486.55",
"icms-17.5": "6054.11",
"icms-19.5": "6204.53",
"icms-20.5": "6282.58",
"icms-22.5": "6444.70",
"icms-12-alc": "5624.08",
"icms-17-alc": "5962.88",
"icms-18-alc": "6035.60",
"icms-19-alc": "6110.11",
"icms-20-alc": "6186.48",
"icms-21-alc": "6264.80",
"icms-22-alc": "6345.12",
"icms-23-alc": "6427.52",
"withoutTaxes": "4949.19",
"icms-17.5-alc": "5999.02",
"icms-19.5-alc": "6148.06",
"icms-20.5-alc": "6225.40",
"icms-22.5-alc": "6386.05"
},
"invalidBarcodes": [],
"activeSubstances": [
"RITUXIMABE"
],
"therapeuticClass": "L1G1 - ANTICORPOS MONOCLONAIS ANTINEOPLÁSICOS, CD20",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1453100050011",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1G1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:556926020000607"